741 related articles for article (PubMed ID: 26620888)
1. Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1/GDF15.
Tsai VW; Lin S; Brown DA; Salis A; Breit SN
Int J Obes (Lond); 2016 Feb; 40(2):193-7. PubMed ID: 26620888
[TBL] [Abstract][Full Text] [Related]
2. Targeting the divergent TGFβ superfamily cytokine MIC-1/GDF15 for therapy of anorexia/cachexia syndromes.
Tsai VW; Brown DA; Breit SN
Curr Opin Support Palliat Care; 2018 Dec; 12(4):404-409. PubMed ID: 30382947
[TBL] [Abstract][Full Text] [Related]
3. The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism.
Breit SN; Johnen H; Cook AD; Tsai VW; Mohammad MG; Kuffner T; Zhang HP; Marquis CP; Jiang L; Lockwood G; Lee-Ng M; Husaini Y; Wu L; Hamilton JA; Brown DA
Growth Factors; 2011 Oct; 29(5):187-95. PubMed ID: 21831009
[TBL] [Abstract][Full Text] [Related]
4. The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases.
Tsai VWW; Husaini Y; Sainsbury A; Brown DA; Breit SN
Cell Metab; 2018 Sep; 28(3):353-368. PubMed ID: 30184485
[TBL] [Abstract][Full Text] [Related]
5. Anorexia-cachexia syndrome in hepatoma tumour-bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC-1/GDF15.
Borner T; Arnold M; Ruud J; Breit SN; Langhans W; Lutz TA; Blomqvist A; Riediger T
J Cachexia Sarcopenia Muscle; 2017 Jun; 8(3):417-427. PubMed ID: 28025863
[TBL] [Abstract][Full Text] [Related]
6. Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15.
Tsai VW; Husaini Y; Manandhar R; Lee-Ng KK; Zhang HP; Harriott K; Jiang L; Lin S; Sainsbury A; Brown DA; Breit SN
J Cachexia Sarcopenia Muscle; 2012 Dec; 3(4):239-43. PubMed ID: 22936174
[TBL] [Abstract][Full Text] [Related]
7. TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator.
Tsai VW; Macia L; Johnen H; Kuffner T; Manadhar R; Jørgensen SB; Lee-Ng KK; Zhang HP; Wu L; Marquis CP; Jiang L; Husaini Y; Lin S; Herzog H; Brown DA; Sainsbury A; Breit SN
PLoS One; 2013; 8(2):e55174. PubMed ID: 23468844
[TBL] [Abstract][Full Text] [Related]
8. [Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].
Inui A
Rinsho Byori; 2006 Oct; 54(10):1044-51. PubMed ID: 17133993
[TBL] [Abstract][Full Text] [Related]
9. Targeting Obesity and Cachexia: Identification of the GFRAL Receptor-MIC-1/GDF15 Pathway.
Breit SN; Tsai VW; Brown DA
Trends Mol Med; 2017 Dec; 23(12):1065-1067. PubMed ID: 29129392
[TBL] [Abstract][Full Text] [Related]
10. Serum Levels of Human MIC-1/GDF15 Vary in a Diurnal Pattern, Do Not Display a Profile Suggestive of a Satiety Factor and Are Related to BMI.
Tsai VW; Macia L; Feinle-Bisset C; Manandhar R; Astrup A; Raben A; Lorenzen JK; Schmidt PT; Wiklund F; Pedersen NL; Campbell L; Kriketos A; Xu A; Pengcheng Z; Jia W; Curmi PM; Angstmann CN; Lee-Ng KK; Zhang HP; Marquis CP; Husaini Y; Beglinger C; Lin S; Herzog H; Brown DA; Sainsbury A; Breit SN
PLoS One; 2015; 10(7):e0133362. PubMed ID: 26207898
[TBL] [Abstract][Full Text] [Related]
11. [Recent development in research and management of cancer anorexia-cachexia syndrome].
Inui A
Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
[TBL] [Abstract][Full Text] [Related]
12. The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?
Breit SN; Brown DA; Tsai VW
Annu Rev Physiol; 2021 Feb; 83():127-151. PubMed ID: 33228454
[TBL] [Abstract][Full Text] [Related]
13. Understanding cachexia and excessive weight loss in cancer.
Hemming L; Maher D
Br J Community Nurs; 2005 Nov; 10(11):492-5. PubMed ID: 16301922
[TBL] [Abstract][Full Text] [Related]
14. Update on anorexia and cachexia.
Strasser F; Bruera ED
Hematol Oncol Clin North Am; 2002 Jun; 16(3):589-617. PubMed ID: 12170570
[TBL] [Abstract][Full Text] [Related]
15. Is the pharmacological treatment of cancer cachexia possible?
Bruera E
Support Care Cancer; 1993 Nov; 1(6):298-304. PubMed ID: 8156247
[TBL] [Abstract][Full Text] [Related]
16. [The cachexia-anorexia syndrome among oncological patients].
Sosa-Sánchez R; Sánchez-Lara K; Motola-Kuba D; Green-Renner D
Gac Med Mex; 2008; 144(5):435-40. PubMed ID: 19043964
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia.
Siddiqui JA; Pothuraju R; Khan P; Sharma G; Muniyan S; Seshacharyulu P; Jain M; Nasser MW; Batra SK
Cytokine Growth Factor Rev; 2022 Apr; 64():71-83. PubMed ID: 34836750
[TBL] [Abstract][Full Text] [Related]
18. Energy imbalance and cancer: Cause or consequence?
Wang X; Liu W; Xie X
IUBMB Life; 2017 Oct; 69(10):776-784. PubMed ID: 28858429
[TBL] [Abstract][Full Text] [Related]
19. Management of weight loss and anorexia.
Hopkinson JB; Wright DN; Foster C
Ann Oncol; 2008 Sep; 19 Suppl 7():vii289-93. PubMed ID: 18790968
[No Abstract] [Full Text] [Related]
20. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
